In addition, genotoxic, ROS-generating drugs such as doxorubicin induce the liberation of IL-6 from endothelial cells in a mechanism that depend on p38 activation, contributing to the induction of senescence in tumor-associated stromal cells [137,138]. The gene discussed is MAPK1; the disease is neoplasm.